cgt - i'm not that hung up on this but let's give it another go.
Yes, both studies involved families
BUT The relenza study reports data at the HOUSEHOLD level
while the LANI study reports data at the level of the individual prophylaxis subject.
in a 4 person household with one flu sufferer and 3 prophylaxis subjects. . . .. If one of the individuals contracted the flu in the relenza study it would mark the household as a positive data point, while in the LANI study it would be one positive data point and two negative data points.
- Forums
- ASX - By Stock
- Ann: Phase III prophylaxis trial for CS-8958
cgt - i'm not that hung up on this but let's give it another...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online